Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of 1,25 Dihydroxycholecalciferol on the Cardiovascular System in Patients With Renal Dysfunction

NCT00175149 is registered in ClinicalTrials.gov with Per Ivarsen as lead sponsor.

NCT NCT00175149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00175149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of 1,25 Dihydroxycholecalciferol on the Cardiovascular System in Patients With Renal Dysfunction
Lead sponsor
Per Ivarsen
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2002
Completion date
December 31, 2008
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, left ventricular hypertrophy, secondary hyperparathyroidism